Cargando…

Adequacy of family history taking in ovarian cancer patients: a population-based study

The aim of this study was to evaluate the adequacy of family history taking in epithelial ovarian cancer (EOC) patients and to identify factors that determine adequacy. Furthermore, the validity of family history taking was assessed by comparison with self-administered questionnaires. Medical record...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Altena, Anne M., van Aarle, Sandra, Kiemeney, Lambertus A. L. M., Hoogerbrugge, Nicoline, Massuger, Leon F. A. G., de Hullu, Joanne A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496539/ https://www.ncbi.nlm.nih.gov/pubmed/22388872 http://dx.doi.org/10.1007/s10689-012-9518-6

Ejemplares similares

Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?
por: Oei, A L M, et al.
Publicado: (2006)

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome
por: Gerritzen, Lotte H. M., et al.
Publicado: (2009)

Surveillance of women at high risk for hereditary ovarian cancer is inefficient
por: Oei, A L, et al.
Publicado: (2006)

A patient decision aid for risk‐reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing
por: Harmsen, Marline G., et al.
Publicado: (2017)

Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population‐based cohort study
por: Said, Sherin A., et al.
Publicado: (2021)

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition
por: Vos, Janet R, et al.
Publicado: (2019)

The prognostic value of family history among patients with urinary bladder cancer
por: Egbers, Lieke, et al.
Publicado: (2015)

Spontaneous Regression of Ovarian Carcinoma After Septic Peritonitis; A Unique Case Report
por: Roelofsen, Thijs, et al.
Publicado: (2018)

Impact of Sepsis on the Oncologic Outcomes of Advanced Epithelial Ovarian Cancer Patients: A Multicenter Observational Study
por: Said, Sherin A., et al.
Publicado: (2023)

Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites
por: Wefers, Christina, et al.
Publicado: (2019)

Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups
por: Witjes, Vera M., et al.
Publicado: (2022)

Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites
por: den Ouden, Judith E., et al.
Publicado: (2020)

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
por: Jongmans, Marjolijn C J, et al.
Publicado: (2011)

Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue
por: van de Nieuwenhof, Hedwig P., et al.
Publicado: (2010)

Survival Is Related to Estrogen Signal Transduction Pathway Activity in Postmenopausal Women Diagnosed with High-Grade Serous Ovarian Carcinoma
por: van Lieshout, Laura, et al.
Publicado: (2021)

Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis
por: van Bommel, Majke H D, et al.
Publicado: (2022)

Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome
por: Reijnen, Casper, et al.
Publicado: (2020)

Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas
por: Weren, Robbert D.A., et al.
Publicado: (2016)

External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancer
por: van de Laar, R, et al.
Publicado: (2014)

Universal genetic assessment for women with ovarian cancer not yet achieved: The promises of universal tumor DNA testing
por: Witjes, Vera M., et al.
Publicado: (2021)

The role of MMP-14 in ovarian cancer: a systematic review
por: Vos, M. Caroline, et al.
Publicado: (2021)

Heritability for stroke: Essential for taking family history
por: Pourasgari, Masoumeh, et al.
Publicado: (2020)

Familial gastric cancer: detection of a hereditary cause helps to understand its etiology
por: Vogelaar, Ingrid P, et al.
Publicado: (2012)

Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome
por: Elze, Lisa, et al.
Publicado: (2023)

Adequacy of ovarian diathermy under ultrasound control: an experimental model
por: Pimentel, Anita Mylius, et al.
Publicado: (2013)

History taking
por: Micieli, Andrew, et al.
Publicado: (2020)

NTHL1 defines novel cancer syndrome
por: Kuiper, Roland P., et al.
Publicado: (2015)

Finding all BRCA pathogenic mutation carriers: best practice models
por: Hoogerbrugge, Nicoline, et al.
Publicado: (2016)

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study
por: Harmsen, Marline G., et al.
Publicado: (2015)

Factors influencing decision-making around opportunistic salpingectomy: a nationwide survey
por: Steenbeek, Miranda P., et al.
Publicado: (2018)

Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial
por: Visser, Annemiek, et al.
Publicado: (2011)

Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors
por: van Bommel, Majke H. D., et al.
Publicado: (2022)

Micronutrient Adequacy in Preschool Children Attending Family Child Care Homes
por: Cuadrado-Soto, Esther, et al.
Publicado: (2019)

Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer
por: Vos, M. Caroline, et al.
Publicado: (2016)

Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes
por: Vos, Janet R., et al.
Publicado: (2018)

Teaching history-taking: where are we?
por: Nardone, D. A., et al.
Publicado: (1980)

“Patient Journeys”: improving care by patient involvement
por: Bolz-Johnson, Matt, et al.
Publicado: (2019)

The efficacy of ultrasound in the follow up after a negative sentinel lymph node in women with vulvar cancer: a prospective single‐centre study
por: Pouwer, AW, et al.
Publicado: (2018)

Exome Sequencing of Germline DNA from Non-BRCA1/2 Familial Breast Cancer Cases Selected on the Basis of aCGH Tumor Profiling
por: Hilbers, Florentine S., et al.
Publicado: (2013)

Ovarian surface epithelium: family history and early events in ovarian cancer
por: Wong, Alice ST, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_6om1smhm3htisgoagntm0ol8aa